1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)

التفاصيل البيبلوغرافية
العنوان: 1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)
المؤلفون: P. Barthelemy, C. Thibault, E. Voog, J-C. Eymard, A. Ravaud, A. Flechon, C. Abraham Jaillon, W. Hilgers, S. Le Moulec, M. Chasseray, D. Pouessel, Y.E. Amela, V. Lorgis, E. Nicolas, E. Kazan, G. Denechere, M-N. Solbes, P. Lambert, Y. Loriot
المصدر: Annals of Oncology. 33:S1341-S1342
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Oncology, Hematology
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fcb0f65bd5698d33a6b1ddd4303b28a2
https://doi.org/10.1016/j.annonc.2022.07.1835
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........fcb0f65bd5698d33a6b1ddd4303b28a2
قاعدة البيانات: OpenAIRE